$ASST
Asset Entities Inc.

2022 Q4 Form 10-K Financial Statement

#000121390023025411 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $62.97K $343.1K
YoY Change -58.64%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $295.2K $988.4K
YoY Change 21.31%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $295.2K $988.4K
YoY Change 21.31%
Operating Profit -$645.3K
YoY Change -4439.02%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$232.3K -$645.3K
YoY Change -4439.34%
Income Tax
% Of Pretax Income
Net Earnings -$232.3K -$645.3K
YoY Change -4439.02%
Net Earnings / Revenue -368.84% -188.06%
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share -$0.05 -$0.06
COMMON SHARES
Basic Shares Outstanding 10.25M shares
Diluted Shares Outstanding 10.25M shares

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $137.2K $137.2K
YoY Change 306.7%
Cash & Equivalents $137.2K $33.73K
Short-Term Investments
Other Short-Term Assets $235.8K $235.8K
YoY Change 843.36%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $373.0K $373.0K $58.73K
YoY Change 535.13% 535.14%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $373.0K $373.0K $58.73K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $373.0K $373.0K $58.73K
YoY Change 535.13% 535.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue $4.648K $6.450K
YoY Change -27.94%
Short-Term Debt $214.6K $214.6K
YoY Change 2247.81%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $219.2K $219.2K $15.59K
YoY Change 1305.91% 1306.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $219.2K $219.2K $15.59K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $219.2K $219.2K $15.59K
YoY Change 1305.91% 1306.29%
SHAREHOLDERS EQUITY
Retained Earnings -$627.1K $18.14K
YoY Change -3557.67%
Common Stock $779.8K $250.0K
YoY Change 211.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $153.8K $153.8K $43.14K
YoY Change
Total Liabilities & Shareholders Equity $373.0K $373.0K $58.73K
YoY Change 535.13% 535.14%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income -$232.3K -$645.3K
YoY Change -4439.02%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$209.6K -$602.8K
YoY Change -2679.5%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $976.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 329.9K $706.3K
YoY Change
NET CHANGE
Cash From Operating Activities -209.6K -$602.8K
Cash From Investing Activities
Cash From Financing Activities 329.9K $706.3K
Net Change In Cash 120.3K $103.4K
YoY Change 342.64%
FREE CASH FLOW
Cash From Operating Activities -$209.6K -$602.8K
Capital Expenditures
Free Cash Flow -$602.8K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41612
CY2022 dei Entity Registrant Name
EntityRegistrantName
ASSET ENTITIES INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-1293236
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
100 Crescent Ct
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
7th Floor
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75201
CY2022 dei City Area Code
CityAreaCode
(214)
CY2022 dei Local Phone Number
LocalPhoneNumber
459-3117
CY2022 dei Security12b Title
Security12bTitle
Class B Common Stock, $0.0001 par value per share
CY2022 dei Trading Symbol
TradingSymbol
ASST
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Name
AuditorName
WWC, P.C.
CY2022 dei Auditor Firm
AuditorFirmId
1171
CY2022 dei Auditor Location
AuditorLocation
San Mateo, CA
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137177 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33731 usd
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
235844 usd
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
25000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
373021 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
58731 usd
CY2022Q4 us-gaap Assets
Assets
373021 usd
CY2021Q4 us-gaap Assets
Assets
58731 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
214590 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9144 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4648 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6450 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
219238 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15594 usd
CY2022Q4 us-gaap Liabilities
Liabilities
219238 usd
CY2021Q4 us-gaap Liabilities
Liabilities
15594 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 asst Common Stock Value One
CommonStockValueOne
839 usd
CY2021Q4 asst Common Stock Value One
CommonStockValueOne
976 usd
CY2022Q4 asst Common Stock Value2
CommonStockValue2
236 usd
CY2021Q4 asst Common Stock Value2
CommonStockValue2
24 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
779826 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
249976 usd
CY2021Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
225976 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-627118 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
18137 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
153783 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
43137 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
373021 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58731 usd
CY2022 us-gaap Revenues
Revenues
343106 usd
CY2021 us-gaap Revenues
Revenues
829618 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
155232 usd
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
160251 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
462971 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
119369 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
370158 usd
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
535127 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
988361 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
814747 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-645255 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
14871 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-645255 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
14871 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10249315 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9767364 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3266 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
14871 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
43137 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
529925 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
225976 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-645255 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
153783 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-645255 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
14871 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
44228 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9144 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1802 usd
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-645 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-602829 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23370 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
976 usd
CY2022 asst Class B Common Stock Subscription Proceeds Received
ClassBCommonStockSubscriptionProceedsReceived
754925 usd
CY2021 asst Class B Common Stock Subscription Proceeds Received
ClassBCommonStockSubscriptionProceedsReceived
25000 usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
49626 usd
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
25000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
706275 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
103446 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
23370 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33731 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10361 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
137177 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33731 usd
CY2022 asst Conversion From Class A To Class B Common Stock
ConversionFromClassAToClassBCommonStock
137 usd
CY2022Q1 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
250000000 shares
CY2022Q1 us-gaap Other Ownership Interests Units Outstanding
OtherOwnershipInterestsUnitsOutstanding
51250000 shares
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-627118 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-645255 usd
CY2022 asst Asset Equity Percentage
AssetEquityPercentage
1 pure
CY2022 asst Net Profits Or Losses
NetProfitsOrLosses
1 pure
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
4648 usd
CY2022Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
6450 usd
CY2022 us-gaap Derivative Cash Received On Hedge
DerivativeCashReceivedOnHedge
250000 usd
CY2021Q4 us-gaap Cash Flow Hedge Derivative Instrument Liabilities At Fair Value
CashFlowHedgeDerivativeInstrumentLiabilitiesAtFairValue
5000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5000 usd
CY2022 asst Effective Dates
EffectiveDates
P2Y
CY2022Q1 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
250000000 shares
CY2022Q1 us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
51250000 shares
CY2022Q2 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
52500 shares
CY2022Q4 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
52500 shares
CY2022Q2 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
6.25
CY2022Q4 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
6.25
CY2022Q4 us-gaap Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
P5Y
CY2022Q2 us-gaap Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
P5Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
52500 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.25
CY2022 asst Weighted Average Lifeyears Granted
WeightedAverageLifeyearsGranted
P5Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
52500 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.25
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y8M4D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022 us-gaap Insurance Agency Management Fee
InsuranceAgencyManagementFee
370158 usd
CY2021 us-gaap Insurance Agency Management Fee
InsuranceAgencyManagementFee
535127 usd
CY2022 us-gaap Gain Loss On Sale Of Leased Assets Net Operating Leases
GainLossOnSaleOfLeasedAssetsNetOperatingLeases
645255 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-135504 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
135504 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
135504 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
135504 usd
CY2022Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
usd
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9767364 shares
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001920406
CY2022Q2 dei Entity Public Float
EntityPublicFloat
0 usd

Files In Submission

Name View Source Status
0001213900-23-025411-index-headers.html Edgar Link pending
0001213900-23-025411-index.html Edgar Link pending
0001213900-23-025411.txt Edgar Link pending
0001213900-23-025411-xbrl.zip Edgar Link pending
asst-20221231.xsd Edgar Link pending
asst-20221231_cal.xml Edgar Link unprocessable
asst-20221231_lab.xml Edgar Link unprocessable
asst-20221231_pre.xml Edgar Link unprocessable
ex10-21_001.jpg Edgar Link pending
ex10-21_002.jpg Edgar Link pending
ex10-22_001.jpg Edgar Link pending
f10k2022ex10-11_asset.htm Edgar Link pending
f10k2022ex10-12_asset.htm Edgar Link pending
f10k2022ex10-13_asset.htm Edgar Link pending
f10k2022ex10-14_asset.htm Edgar Link pending
f10k2022ex10-21_asset.htm Edgar Link pending
f10k2022ex10-22_asset.htm Edgar Link pending
f10k2022ex31-1_asset.htm Edgar Link pending
f10k2022ex31-2_asset.htm Edgar Link pending
f10k2022ex32-1_asset.htm Edgar Link pending
f10k2022ex32-2_asset.htm Edgar Link pending
f10k2022ex4-1_asset.htm Edgar Link pending
f10k2022ex4-2_asset.htm Edgar Link pending
f10k2022ex4-3_asset.htm Edgar Link pending
f10k2022ex4-4_asset.htm Edgar Link pending
f10k2022_assetentities.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img_001.jpg Edgar Link pending
img_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
f10k2022_assetentities_htm.xml Edgar Link completed
asst-20221231_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable